TL;DR
A healthcare data strategy is an organization-wide plan that ties clinical, financial and member outcomes to decisions about data ownership, exchange, architecture and funding. To build one, start with three to five measurable outcomes and give each an executive owner. After that, rate every data source red, amber or green for readiness. Then treat HIPAA, information blocking and CMS payer API deadlines as dated roadmap gates with named owners. Choose the architecture only once those requirements are clear. Finally, prove one bounded value case in the first 90 days, because that result is what wins funding for the full roadmap.
Key Takeaways A healthcare data strategy starts from three to five measurable outcomes, rather than from a platform purchase or an AI pilot. The strategy is a short set of decisions with owners, covering outcomes and scope, ownership, trust, architecture and execution. Health systems, payers and life sciences firms share data problems, but their value cases and rules differ. Interoperability and privacy rules such as CMS-0057-F, information blocking and HIPAA belong on the roadmap as dated gates. AI readiness is judged per use case, because data that is accessible is not automatically fit for an AI workflow. The first 90 days should end with one proven value case and an approved, funded roadmap. Watch on YouTube
State of Enterprise AI 2026: Data Foundations, Maturity Stages & ROI
Kanerika looks at where enterprises stand on AI in 2026, from data foundations through maturity stages to ROI, the groundwork a healthcare data strategy has to lay first.
One Lab Result, Five Systems
Follow one hypothetical record. A patient we will call Patient R has a routine A1C blood test at a hospital outpatient lab. At first, the result appears only in the lab system, under a local test code.
Within the hour, the electronic health record files it against Patient R’s medical record number. Weeks later in this example, the health plan sees only a claim line for the visit, under a member ID. As a result, the plan’s care team never sees the lab value itself.
Then a research group asks to include the result in a diabetes study. But nobody can say quickly whether that use is permitted. Meanwhile, an AI model that flags gaps in care reads the claim, not the lab value, and misses the change.
Every hop in this story worked as designed. Yet no one had decided which version of the result counts, who owns Patient R’s identity across systems, or who approves reuse. Those three missing decisions are what a healthcare data strategy exists to make, in writing, before the next system goes live.
What Is a Healthcare Data Strategy?
A healthcare data strategy is an organization-wide plan that connects clinical and business priorities to decisions about data. Those decisions cover ownership, interoperability, architecture, governance, funding and measurable outcomes. It also sets the order in which the work happens, as a sequenced roadmap.
The plan is easier to define by what it is not. A strategy is not an architecture diagram, a governance policy or a project backlog. Instead, each of those is a deliverable that the strategy decides it needs.
Strategy vs Architecture, Governance and Analytics
The table below separates five disciplines that are easy to blur together. When they blur, funding requests compete instead of building on each other.
Discipline Question it answers Accountable owner Data strategy Which outcomes matter, and in what order do we fund them? Executive sponsor with a chief data officer Data architecture How do systems store, move and serve the data? Enterprise or data architect Data governance Who may use which data, and under what rules? Governance council and data owners Analytics and BI What happened, and why? Analytics leader Digital transformation How do care and operations change? Chief executive team
Each row deserves its own plan, and two of them have separate Kanerika guides. For policy, see the guide to healthcare data governance . Then, for the operating side, read about healthcare digital transformation .
Kanerika Service
Data Governance Services
Kanerika sets up the policies, ownership and access controls that let a data strategy’s trust decisions hold in daily operations.
Explore Data Governance What a Finished Strategy Contains
A finished strategy is a short document with owners. A slide deck of ambitions does not count. It should hold at least these parts.
An outcome list, with an executive owner and a baseline for each outcome A data domain map covering clinical, claims, member, research and operational data Guiding principles, such as minimum necessary access, reuse before duplication and clinical safety before speed Target capabilities and a funding model for running them A sequenced roadmap, together with a KPI contract for each funded initiative The minimum necessary principle, for example, comes straight from the HIPAA Privacy Rule. Under 45 CFR 164.502(b) , covered entities must make reasonable efforts to limit protected health information to what a purpose needs. Treatment disclosures between providers, though, are among the exceptions.
Four Pressures Behind a Healthcare Data Strategy
Exchange between hospitals is still partial. According to an ONC data brief on 2023 hospital data , 70% of non-federal acute care hospitals did all four exchange tasks at least sometimes. Those tasks are send, find, receive and integrate. But only 43% did all four routinely.
Payers, meanwhile, face hard dates. CMS released its Interoperability and Prior Authorization final rule, CMS-0057-F, on January 17, 2024. Its operational provisions have applied since January 1, 2026, and its API requirements apply primarily from January 1, 2027.
Information blocking also carries consequences for providers as of November 2026. HHS published a final rule on disincentives for providers found to have blocked information on July 1, 2024. In addition, ONC’s HTI-5 final rule takes effect on December 28, 2026, moving certification further toward FHIR-based APIs.
Concentration risk is the last pressure. In February 2024, a ransomware attack on Change Healthcare affected an estimated 192.7 million people, according to HIPAA Journal’s tracking of the breach count . Claims and payment processing were then disrupted for around two months. For that reason, a strategy should name its single points of failure next to its goals.
Kanerika Service
Healthcare Data and AI Solutions
Kanerika designs interoperability frameworks that connect EHR, PACS, LIMS and billing systems using FHIR and HL7 standards.
See Healthcare Solutions How Priorities Differ for Health Systems, Payers and Life Sciences
All three segments struggle with identity, quality and access. However, their value cases and their regulators differ, and a strategy copied from another segment will fund the wrong work first.
Segment Priority outcomes Data it depends on Rules that shape it Health systems Capacity, care quality, revenue cycle EHR, ADT feeds, scheduling, claims HIPAA, information blocking Payers Prior authorization, member experience, provider data Claims, member identity, clinical data mapped to USCDI CMS-0057-F, HIPAA Life sciences Trials, drug safety, real-world evidence Trial, safety and real-world data, with provenance and consent HIPAA where it applies, EU rules for EU operations
For a health system, a clinical data strategy can lead, because patient flow and documentation drive both care and revenue. Payers, in contrast, are working against CMS deadlines. Under CMS-0057-F, impacted payers must decide expedited prior authorization requests within 72 hours and standard ones within seven calendar days.
Life sciences teams, on the other hand, put provenance and permitted use first. For drug safety data, also see the sibling guide on AI in pharmacovigilance . Trial data teams can also read about AI in clinical data management .
Multinational firms also have one more date to track. The European Health Data Space regulation entered into force on March 26, 2025, and key parts apply from March 2029. Whatever the segment, operational use cases still belong in a separate plan. The guide to healthcare analytics use cases covers them in depth.
A Healthcare Data Strategy Framework: Five Decisions
The framework below is a practical synthesis, not an industry standard. It reduces the strategy to five decisions, taken in order, each with a named owner.
Outcomes and scope, before anything else. Decide what must improve and which domains are in play. Otherwise, every department brings its own priority list, and the roadmap turns into a queue.
Ownership, once outcomes are set. Decide who decides, who funds and who fixes data at the source. Without it, quality defects bounce between IT and clinical teams with no end date.
Trust, before any data is used. Decide the privacy, quality and identity rules that data must pass. When this step is missing, every dashboard carries a footnote and nobody acts on it.
Architecture, only after that. Choose platforms and patterns once you know the requirements. Starting here risks buying capacity before anyone knows what to put in it.
Execution, once those choices are made. Sequence the roadmap by dependency, value and risk. Then fund it in stages, so each stage has to earn the next one.
Other published frameworks fit inside these five. For instance, a pillar such as “data governance” sits inside trust and ownership, while “advanced analytics” belongs to outcomes and execution. The order matters more than the labels, because architecture chosen before ownership is hard to reverse.
How to Build a Healthcare Data Strategy, Step by Step
The steps below turn the five decisions into work. Each step ends with an artifact that the following step needs.
Step 1: Anchor on Three to Five Outcomes
Pick outcomes that a clinical or business leader already reports on. For example, good candidates are prior authorization turnaround, avoidable denials, operating room use or trial enrollment speed. Each outcome then gets one executive owner and a current baseline.
Treat five as a ceiling. Past that point, the strategy starts to describe everything the organization does, and it stops guiding funding choices.
Step 2: Baseline Your Data and Readiness
Once outcomes are set, inventory the sources each one depends on. That list covers sources such as EHR, claims, lab, imaging, research and third-party data. For each source, record access rights, quality, refresh rate, lineage and the effort needed to integrate it.
This inventory should also feed the HIPAA risk analysis, so nobody builds it twice. The Security Rule at 45 CFR 164.308 already requires an accurate and thorough assessment of risks to electronic protected health information. Sharing one inventory therefore saves both teams a second round of interviews.
Then rate each source with a readiness gate. Red blocks a safe pilot, for example when there is no lawful access path or no way to match patient identity. Amber, by comparison, means a fix can happen in flight and improve incrementally. Finally, green means the source can proceed to the pilot.
Governance gaps can surface at this point. When they do, a structured method for assessing governance maturity keeps the conversation factual.
Step 3: Score and Pick Value Cases
Once you know outcomes and readiness, score candidate projects on the same scale. The weights here are illustrative, and each organization should set its own.
In this example, strategic fit with a named outcome carries 25% of the score. Expected benefit and data readiness carry 20% each, while privacy and patient safety risk carries 15%. Finally, reuse potential and time to adoption carry 10% each.
Beyond the ranking, the scorecard is just as useful for what it rejects. Write down which projects you will defer or stop, and why. That list protects the roadmap when a new request arrives with a loud sponsor.
Step 4: Write a KPI Contract Before You Build
A KPI contract is a one-page agreement for each funded case. It states the baseline, target, denominator, period, owner and data source. It also states what the metric cannot prove, such as attribution when two programs touch the same patients.
Track three kinds of measure at the same time. The first is the outcome itself. Then comes adoption by the people who should change behavior. Last comes foundation health, such as data freshness and the pass rate of quality rules from your data quality framework .
Operating Model: Ownership, Decision Rights and Funding
A strategy without clear ownership stalls, whatever the technology. Decision rights make ownership concrete, because they say who signs off on what.
For example, approving an outcome belongs to the executive sponsor. Granting data access belongs to the data owner, while privacy and security teams give input. Fixing a quality defect belongs to whoever owns the source system, not to the analyst who found it. Meanwhile, an architecture exception goes to the architecture board, and release acceptance goes to the business owner of the use case.
In addition, treat shared data sets as products with owners. Each product needs a purpose, known consumers, quality expectations, access conditions and lifecycle funding. Business accountability stays with the domain, while technical upkeep can sit with a platform team.
Funding, in the end, is where the model succeeds or fails. Project budgets end at go-live, but stewardship, integrations, platform operations, training and monitoring keep costing money. For that reason, the strategy should fund those run costs as a line item from day one.
For the policy layer behind these rights, a data governance framework sets out councils, stewards and escalation paths.
Checklist
Enterprise Data Governance Checklist
A practical checklist for the ownership, policies and controls that turn decision rights into day-to-day practice.
Get the Checklist → Interoperability, Privacy and Regulation as Roadmap Gates
Regulations shape the strategy in two ways. They set dates the roadmap cannot move, and then they decide which data may flow where. The strategy’s job, therefore, is to give each obligation an owner and tie it to the roadmap items it gates.
The summary below reflects the status of each rule as of November 2026. It is general guidance, not legal advice, so confirm how each rule applies to your organization with counsel.
Obligation Status as of November 2026 What it forces into the strategy HIPAA Privacy and Security Rules In force; Security Rule update still proposed Minimum necessary access and a current risk analysis 42 CFR Part 2 Compliance date February 16, 2026 Segmented handling of substance use disorder records Information blocking In force, with provider disincentives since 2024 Release paths for electronic health information CMS-0057-F Operational rules since January 1, 2026; APIs due January 1, 2027 Payer API delivery and prior authorization metrics CMS-0062-P Proposed only, not final Watch item for drug prior authorization EHDS In force in the EU; key parts apply from 2029 Planning for EU operations only
What Each Rule Means for the Roadmap
Some rows in the table need more detail than a cell allows. HHS published its proposed HIPAA Security Rule update on January 6, 2025. As of November 2026, the Federal Register shows no final rule, so treat its contents as a proposal rather than an obligation.
The 42 CFR Part 2 final rule brought substance use disorder records closer to HIPAA. Its compliance date was February 16, 2026. For the data platform, that means those records need their own labels and access rules.
Watch on YouTube
Transform Your Data Strategy with Microsoft Purview: Governance, Security & Growth
Kanerika explains how Microsoft Purview brings governance and security controls into a data strategy, including the classification and access policies that regulated data needs.
Information blocking rules apply to providers, certified health IT developers, and health information exchanges and networks. The definition sits in 45 CFR 171.103 , while the exceptions appear in the same part. In practice, a strategy should name who handles access requests and how quickly.
For payers, the CMS-0057-F fact sheet lists the APIs due by January 1, 2027. These include a Provider Access API as well as a Payer-to-Payer API, both sharing claims, encounter data and USCDI data elements. In April 2026, CMS also issued proposed rule CMS-0062-P , which would extend electronic prior authorization to drugs from October 1, 2027. As of November 2026, it remains a proposal rather than a rule in force.
Deeper policy guidance lives in the guide to governing healthcare data . For build-side controls, see HIPAA-compliant software development .
HL7, FHIR, USCDI and TEFCA Are Different Layers
These four names can appear in a single sentence, but they do different jobs. Mixing them up can lead to roadmap items like “become FHIR compliant,” which no one can finish.
USCDI sets which data elements systems exchange. Since July 23, 2026, USCDI v7 has been the latest version, adding 31 new data elements.FHIR sets how the data is shaped and requested through APIs. FHIR R5 is the current published version, while CMS payer APIs reference FHIR Release 4.0.1.HL7 is the standards body that publishes FHIR, along with older standards such as v2 messaging and CDA.TEFCA covers which networks exchange the data. Under TEFCA , Qualified Health Information Networks exchange data with each other, and the first ones were designated in December 2023.Terminology, though, sits underneath all four layers. Local lab codes, like the one on Patient R’s result, still have to map to shared code sets. The sibling guide to data standardization explains how to run that mapping as an owned, repeatable process.
Architecture and Build-vs-Buy Decisions
Architecture follows requirements, and at this point the requirements exist. A reference flow is then simple to describe. Data moves from sources through ingestion and exchange, then identity and terminology services, then storage and processing. After that come governed access, consumption and monitoring.
Four patterns are worth comparing. For example, a warehouse suits stable, structured reporting. A lakehouse suits mixed clinical, claims and unstructured data that also feeds machine learning. Federated access suits data that must stay in place, while hybrid designs combine these approaches when legacy systems will run for years.
No platform makes an organization HIPAA compliant by itself, and neither does a business associate agreement. Instead, compliance comes from how the organization configures, governs and operates the platform. Similarly, landing-zone policies for PHI workloads belong in your cloud governance rules, not in each project.
After that, build, buy or combine is a separate call for each component. Interoperability engines, master patient indexes, catalogs and orchestration tools all qualify. Then judge each one on integration burden, lock-in, run cost and team capacity. For platform detail, compare Microsoft Fabric for healthcare with Databricks for healthcare data .
AI Readiness Is a Data Strategy Decision
AI pilots expose weak decisions made earlier in the strategy. Because of that, AI readiness belongs inside the strategy, assessed one use case at a time.
A simple ladder helps here, because each rung builds on the one below. Data is first available, then trustworthy and meaningful. After that, it becomes fit for a named analytical task. Finally, it becomes fit for a named AI workflow, with evaluation and monitoring in place.
The ladder also explains why one data set can sit on two rungs at once. Patient R’s claim, for example, was accurate enough for billing and cost reports. Yet a care-gap model that read only that claim missed the A1C value entirely, because the claim never carried it.
Each rung has its own checks, and they get stricter as you climb. Before an AI workflow, confirm provenance, representativeness, label quality and the risk of training on future information. Also confirm permitted use, retrieval permissions and a held-out evaluation set. Human oversight should then scale with the clinical or financial risk of the decision.
What HTI-5 Changes for AI Transparency
Regulation is also moving here. ONC’s HTI-5 final rule , published October 28, 2026, removes 14 certification criteria and revises 7. It also drops the decision support “source attribute” requirements that worked like model cards. As a result, certified health IT no longer has to show those source attributes, and the level of model transparency becomes a governance decision.
For the controls side, read about healthcare AI governance and generative AI in healthcare . A formal AI readiness assessment can then score each candidate use case. Natural-language analytics also depends on shared metric definitions, as the sibling post on generative BI explains.
Watch on YouTube
Fueling Business Growth with AI in Healthcare | Kanerika
Kanerika’s healthcare client story on putting AI and machine learning to work, showing what a named AI workflow looks like once the data behind it is ready.
Your First 90 Days and the Signs a Strategy Is Failing
The first 90 days mobilize the strategy itself. They end with an approved, funded roadmap and one validated value case, rather than a finished platform.
Period Focus Exit artifact Days 1 to 30 Interviews, source inventory, outcome shortlist Agreed outcomes with owners Days 31 to 60 Target state, scorecard, decision rights, gate map Ranked value cases Days 61 to 90 Validate one bounded value case Approved, funded roadmap
Pick a value case for the third month that the readiness gates rated green or amber. After all, a red-rated case will spend the whole period on access approvals. Where a legacy platform blocks progress, plan the move as its own workstream, as covered in the guide to healthcare data migration .
Warning Signs and Their Fixes
Watch for these warning signs once the roadmap is running. Each one has a direct fix.
Platform-first spend. Money flows to tools before outcomes have owners. Instead, freeze new spend until Step 1 is signed.Ownerless KPIs. Metrics exist, but nobody acts when they move. The fix is to attach each KPI contract to a named person.Pilot sprawl. Pilots multiply, but none reaches production. Cap active pilots, then score each one against the same table.Governance as a bottleneck. Access requests wait in a queue for weeks. In this case, publish pre-approved access patterns for common uses.Underestimated identity matching. Records for one patient stay split across systems. Fund identity services as shared infrastructure, since every use case depends on them.No adoption owner. Dashboards ship, but behavior does not change. Name a business owner for adoption in every case before release.None of these signs calls for a new platform. Instead, each one points back to a decision from the framework that still lacks an owner, and assigning that owner is the first fix.
Kanerika Service
Data Strategy Consulting
Kanerika assesses data maturity, then builds a roadmap with initiatives sequenced by cost, risk and value and every milestone mapped to an owner.
Explore Data Strategy How Kanerika Helps Healthcare Teams Build a Data Strategy
Kanerika’s data strategy consulting service covers the full lifecycle, from maturity assessment through architecture, governance and live execution. According to the service page, the first stage is a data maturity assessment. Then comes a strategy and roadmap, with initiatives sequenced by cost, risk and value and each milestone mapped to an owner.
The later stages cover architecture and platform, governance and compliance, data quality management and a data operating model. Governance work also includes access policies, audit trails and sensitive-data classification with Microsoft Purview, which connects to Kanerika’s data governance services . Clients then choose an Advisory Blueprint, a Hands-On Build or a Fully Managed model.
On the healthcare side, Kanerika’s healthcare practice designs interoperability frameworks that connect EHR, PACS, LIMS and billing systems using FHIR and HL7 standards. Kanerika is also a Microsoft Solutions Partner for Data and AI and a Microsoft Fabric Featured Partner. In addition, it is a certified Databricks partner and a Snowflake Select Tier Partner. It also holds ISO 27001, ISO 27701 and SOC 2 Type II.
Healthcare Case Work
The trust decision, for instance, shows up in Kanerika’s own case work. A clinical research and analytics provider operating in over 100 countries relied on manual SAS programming to convert raw data. Kanerika then used Trifacta to simplify extraction, transformation and cleaning, preparing data for research and machine learning projects.
The published results were a 40% increase in operational efficiency, a 45% improvement in user productivity and 60% faster data integration. The full story is in the clinical research data case study .
Case Study
60% Faster Data Integration for a Clinical Research Provider
Kanerika replaced manual SAS programming with Trifacta-based extraction, transformation and cleaning, with a 40% increase in operational efficiency and a 45% improvement in user productivity.
Read the Case Study → Shared definitions, similarly, matter just as much. In a separate healthcare provider case study , Kanerika put one rule framework over clinical, claims and billing data during an Informatica-to-Databricks migration. If you are still comparing outside firms, the guide to evaluating data strategy companies sets out selection criteria. When you are ready to scope your own plan, talk to our team .
Building a Healthcare Data Strategy That Gets Funded
Patient R’s lab result moved through five systems without an error, and still nobody could use it well. That gap is what a healthcare data strategy closes.
Build it, then, as a sequence of decisions. Pick three to five outcomes with owners, baseline your sources with readiness gates, and score value cases on one table. Put every regulatory date on the roadmap as a gate, choose architecture last, and prove one bounded value case within 90 days. In the end, that proof is what earns the funding for everything after it.
Frequently Asked Questions
What is a healthcare data strategy?
A healthcare data strategy is an organization-wide plan that ties clinical, financial and member outcomes to decisions about data. It covers ownership, interoperability, architecture, governance and funding, and it sets the order of the work as a roadmap. Its purpose is to make sure each data investment serves a measurable outcome with a named owner.
What are the main components of a healthcare data strategy?
A finished strategy has an outcome list with owners and baselines, a data domain map and a short set of guiding principles. It also defines target capabilities, a funding model that covers run costs, decision rights and a sequenced roadmap. Each funded initiative should carry a KPI contract that states the baseline, target, owner and data source.
How do you create a healthcare data strategy roadmap?
Start with three to five outcomes and baseline the data sources each one needs. Rate every source red, amber or green for readiness, then score candidate value cases on one weighted table. Place regulatory dates on the roadmap as gates, choose architecture after requirements are clear, and fund the work in stages that each have to earn the next.
How is a data strategy different from data governance in healthcare?
A data strategy decides which outcomes matter, who owns them and in what order the organization funds the work. Data governance sets the policies, roles and controls for how data may be used. Governance is one deliverable the strategy calls for, sitting mostly inside its trust and ownership decisions, rather than a replacement for the strategy itself.
How do FHIR, HL7 and TEFCA fit into a healthcare data strategy?
They are separate layers. HL7 is the standards body, FHIR is its API and resource standard, USCDI lists which data elements are exchanged, and TEFCA is the network-of-networks framework. A strategy should name an owner for each layer that applies and tie it to roadmap items, such as payer API delivery dates under CMS-0057-F.
How long does it take to build a healthcare data strategy?
For a bounded scope, a working assumption is about 90 days to reach an approved, funded roadmap and one validated value case. The first month covers interviews and inventory, the second sets the target state and scorecard, and the third tests one value case. Larger or multi-entity organizations should expect the scope, and the timeline, to grow.
What are the signs that a healthcare data strategy is failing?
Warning signs include tool spending before outcomes have owners, KPIs that nobody acts on and pilots that never reach production. Others are access requests stuck in long queues, patient records still split across systems and dashboards that do not change behavior. Each sign points to a decision the strategy skipped or left without an owner.
When should a healthcare organization bring in outside data strategy help?
Outside help makes sense when internal teams lack time for a structured assessment, when regulatory deadlines are close, or when leaders disagree on priorities and need a neutral facilitator. A partner should leave behind owned decisions and a funded roadmap. The goal is internal capability, not a long dependency on the consultant who wrote the plan.
Does a cloud platform make healthcare data HIPAA compliant?
No platform makes an organization HIPAA compliant by itself, and neither does a business associate agreement alone. Compliance depends on how the organization configures access, runs its risk analysis, limits data to the minimum necessary and monitors use. Treat this as general guidance and confirm specific obligations with legal counsel for your own situation.
